Marsha Reyngold
Overview
Explore the profile of Marsha Reyngold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chuong M, Ashman J, Jethwa K, Kharofa J, Koay E, Ludmir E, et al.
Int J Radiat Oncol Biol Phys
. 2025 Mar;
PMID: 40032056
Radiation therapy for locally advanced pancreatic cancer (LAPC) continues to be controversial. Advances in both systemic therapy and radiation therapy techniques have changed the landscape of LAPC management in recent...
2.
Cloyd J, Sarna A, Arango M, Bates S, Bhutani M, Bloomston M, et al.
JAMA Surg
. 2024 Dec;
160(2):172-180.
PMID: 39630427
Importance: Neoadjuvant therapy (NT) is an increasingly used treatment strategy for patients with localized pancreatic ductal adenocarcinoma (PDAC). Little research has been conducted on cancer care delivery during NT, and...
3.
OBrien D, Hristidis V, Chakrani Z, McCann P, Damato A, Williams V, et al.
Int J Radiat Oncol Biol Phys
. 2024 Nov;
121(4):951-962.
PMID: 39536799
Purpose: Patterns of failure and salvage therapy options for patients with anal squamous cell carcinoma (ASCC) who recur after definitive-intent intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy are not well...
4.
Sanford N, Narang A, Aguilera T, Bassetti M, Chuong M, Erickson B, et al.
Int J Radiat Oncol Biol Phys
. 2024 Nov;
121(4):918-929.
PMID: 39510320
Purpose: Dose-escalated radiation therapy is increasingly used in the treatment of pancreatic cancer; however, approaches to target delineation vary widely. We present the first North American cooperative group consensus contouring...
5.
Chuong M, Hosni A, Kharofa J, Reyngold M, Sanford N, Rubio Rodriguez M, et al.
Clin Transl Radiat Oncol
. 2024 Sep;
48:100841.
PMID: 39262840
This is a Letter to the Editor in response to the manuscript titled, "Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol"...
6.
Adames A, Roth OBrien D, Kelly A, Saltz L, Garcia-Aguilar J, Zinovoy M, et al.
Int J Colorectal Dis
. 2024 May;
39(1):75.
PMID: 38780794
Background: Palmar-plantar erythrodysesthesia (PPE) is a slowly developing cutaneous reaction commonly experienced by patients treated with fluoropyrimidines. While erythrodysesthesia normally presents in a palmar-plantar distribution, it can also present with...
7.
Dee E, Ng V, OReilly E, Wei A, Lobaugh S, Varghese A, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731159
The rate of isolated locoregional recurrence after surgery for pancreatic adenocarcinoma (PDAC) approaches 25%. Ablative radiation therapy (A-RT) has improved outcomes for locally advanced disease in the primary setting. We...
8.
Chen I, Jeong J, Romesser P, Hilal L, Cuaron J, Zinovoy M, et al.
Adv Radiat Oncol
. 2024 Feb;
9(2):101382.
PMID: 38370274
Purpose: Colorectal liver metastases (CLMs) represent a radioresistant histology. We aimed to investigate CLM radiation therapy (RT) outcomes and explore the association with treatment parameters. Methods And Materials: This retrospective...
9.
Chami P, Diab Y, Khalil D, Azhari H, Jarnagin W, Abou-Alfa G, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069095
The liver tumor immune microenvironment has been thought to possess a critical role in the development and progression of hepatocellular carcinoma (HCC). Despite the approval of immune checkpoint inhibitors (ICIs),...
10.
Wu C, Murray V, Siddiq S, Tyagi N, Reyngold M, Crane C, et al.
Phys Med Biol
. 2023 Aug;
68(18).
PMID: 37619588
. To develop real-time 4D MRI using MR signature matching (MRSIGMA) for volumetric motion imaging in patients with pancreatic cancer on a 1.5T MR-Linac system.. Two consecutive MRI scans with...